Search research articles
Contact Us
Filters
Showing results (561-570 of 703) with videos related to
Page
of 71
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
Georgina V Long, Jeffrey S Weber, Jeffrey R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Angela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
Science (New York, N.Y.)
|
June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
Arcadi Cipponi, David L Goode, Justin Bedo, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
Nature Communications
|
May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes
Manik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2020
Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
Cancer Cell
|
February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Nature Medicine
|
May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
Claus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Page
of 71
Search research articles
Search
Showing results (561-570 of 703) with videos related to
Sort By:
Page
of 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
Georgina V Long, Jeffrey S Weber, Jeffrey R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Angela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
Science (New York, N.Y.)
|
June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
Arcadi Cipponi, David L Goode, Justin Bedo, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
Nature Communications
|
May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes
Manik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2020
Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
Cancer Cell
|
February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Nature Medicine
|
May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
Claus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Page
of 71